C

CorMedix
D

CRMD

7.72000
USD
-0.05
(-0.64%)
Post Trading·7.83000USD+0.11000(+1.42%)
حجم التداول
26,321
الربح لكل سهم
0
العائد الربحي
-
P/E
4
حجم السوق
601,730,181
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ سنة
buy
C
CRMDCorMedix
2024-10-03 08:52
CRMD Chart
المزيد
أصول ذات صلة المقالات
المزيد

العنوان: CorMedix

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.